drugset / Trial / NCT04819932

Pharmacokinetics and Safety of DWJ1451 in Healthy Adults

NCT04819932 ↗

Phase 1 Unknown 64 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

Amlodipine, olmesartan, total ezetimibe, rosuvastatin AUCt, Cmax

Timeline

Start
2021-03-13
Primary completion
2021-03-13
Completion
2021-04-02

Drugs

EvaluationDrugModalityDoseRoute
Subject DWC202008 Unknown — —
Subject DWC202009 Unknown — —
Subject DWJ1451 Unknown — —

Indications

No indication recorded.